Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM)

Neuropathology and Applied Neurobiology

Volumn 29, Issue 6, 2003, Pages 546-552

  Civatte, M ^a   Schleinitz, N ^b   Krammer, P ^b   Fernandez, C ^a   Guis, S ^b   Veit, V ^b   Pouget, J ^c   Harle J R ^b   Pellissier, J F ^a   Figarella Branger, D ^a,d  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c TIMONE HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Class I MHC; DM (dermatomyositis); Immunodetection

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; PERIFASCICULAR ATROPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOLEMMA;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; DERMATOMYOSITIS; ELECTROMYOGRAPHY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES;

EID: 10744220559     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00471.x     Document Type: Article

References (27)

1. Appleyard ST, Dunn MJ, Dubowitz V, Rose ML. Increased expression of HLA ABC class 1 antigens by muscle fibers in Duchenne muscular dystrophy, inflammatory myopathy and other neuromuscular disorders. Lancet 1985; 2: 361-3
2. Arahata K, Engel A. Mononuclear cells in myopathies: quantification of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17: 704-21
3. Bao SS, King NJ, Dos Remedios CG. Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with IFN-γ. Immunol Cell Biol 1990; 68: 235-41
4. Bohan A, Peter JB Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-7, 403-7
5. Dalakas MC. Immunopathogenesis of inflammatory myopathies. Ann Neurol 1995; 37: S74-S86
6. De Visser M, Emslie-Smith AM, Engel AG. Early ultrastructural alterations in adult dermatomyositis capillaries abnormalities precede other structural changes in muscle. J Neurol Sci 1989; 94: 181
7. Emslie-Smith A, Arahata K, Engel A. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxcity in myopathies. Hum Pathol 1989; 20: 224-31
8. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990: 27: 343-7
9. Engel AG, Hohlfeld R, Banker BQ. Inflammatory myopathies: the polymyositis and dermatomyositis syndromes. In Myology. Eds H McGraw, AG Engel, C Franzini-Amstrong. New York: McGraw-Hill 1994; 1335-83
10. Englund F, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 2001; 159: 1263-73
11. Figarella-Branger D, Lacroix C, Coquet M, Gherardi R, Pellissier JF. Myopathies inflammatories idiopathiques. Ann Pathol 2001; 21: 279-84
12. Figarella-Branger D, Nedelec J, Pellissier JF, Boucraut J, Bianco N, Rougon G. Expression of various NCAM (Neural Cell Adhesion Molecule) isoforms and their highly polysialylated counterparts in diseased human muscles. J Neurol Sci 1990; 98: 21-36
13. Figarella-Branger D, Pellissier JF, Bianco N, Devictor B, Toga M. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol 1990; 79: 528-36
14. Illa I, Gallardo E, Gimeno R, Serrano C, Ferrer I, Juarez C. Signal transducer and activator of transcription 1 in human muscle: implications in inflammatory myopathies. Am J Pathol 1997; 151: 81-8
15. Isenberg DA, Rowe DJ, Shearer M, Novick D, Beverley PC. Localization of IFN and interleukin 2 in polymyositis and muscular dystrophy. Clin Exp Immunol 1986; 63: 450-8
16. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1998; 23: 64-72
17. Kissel JT, Mendell JR, Rammohen KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986; 314: 329-34
18. Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF. Local expression of cytokines in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 1998; 24: 73-9
19. Michaelis D, Goebels N, Hohlfeld R. Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol 1993; 143: 1142-9
20. Muller-Felber W, Pongratz D, Reimers C. 64th ENMC Internation Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis 29-31 January 1999, Naarden, The Netherlands. Neuromusc Dis 2001; 11: 88-92
21. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, Lee E, Danning C, Wada R. Thompson C, Bahtiyar G, Craft J, Hooft Van Huijsduijnen R, Plotz P. Conditional upregulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis specific autoantibodies. PNAS 2000; 97: 9209-14
22. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998; 113: 407-14
23. Nyberg P, Wilkman AL, Nennesmo I, Lundberg I. Increased expression of interleukin 1α and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheum 2000; 27: 940-8
24. Rowland LP, Clarke V, Olarte M. Therapy for dermatomyositis and polymyositis. In Advances in Neurology. Ed. P Raven, RC Griggs, RT Moxley. New York: Raven Press, 1977; 63-97
25. Pavlath GK. Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression on myogenesis. J Neuroimmunol 2002; 125: 42-50
26. Sewry CA, Dubowitz V. Histochemistry and immunohistochemistry. In Disorders of Voluntary Muscles 7th edn. Eds G Karpati, D Hilton-Jones, R Griggs. Cambridge: Cambridge University Press. 2001; 251-82
27. Topaloglu H, Muntoni F, Dubowitz V, Sewry C. Expression of HLA Class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis. J Child Neurol 1997; 12: 60-3